Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Sep 8, 2018 at 8:35 AM EDT

Apple Rolls on as Dow’s Top-Performing Stock

Apple held on to its position as the best performing Dow stock for the year to date last week. Next…

Paul Ausick | Sep 6, 2018 at 4:01 PM EDT

Boeing, Visa Prop Up the Dow Thursday

Boeing, Visa, Merck, and Verizon posted large enough gains to keep the Dow in the green Thursday.

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Paul Ausick | Aug 25, 2018 at 8:40 AM EDT

Nike Back on Top as Dow’s Best-Performing Stock

Nike stock added more than 3% to its share price last week, leading the company to wrestle away from Apple…

Jon C. Ogg | Aug 23, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Paul Ausick | Aug 20, 2018 at 4:01 PM EDT

Nike, Johnson & Johnson Lift the Dow Monday

Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.

Paul Ausick | Aug 18, 2018 at 8:50 AM EDT

Apple Returns to Perch as Dow Top-Performing Stock

After an absence of more than a year, Apple is once more the top-performing Dow stock for the year to…

Jon C. Ogg | Aug 15, 2018 at 11:50 AM EDT

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors.…

Chris Lange | Aug 10, 2018 at 9:50 AM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 27, 2018 at 10:40 AM EDT

Merck Underwhelms Despite Beating Earnings

Merck reported better-than-expected second-quarter results before the markets opened on Friday, but shares retreated afterward.

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 22, 2018 at 10:40 AM EDT

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of Boeing, Exxon, Verizon and other Dow industrials scheduled to report their…

Lee Jackson | Jul 20, 2018 at 8:00 AM EDT

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good…

1 … 19 20 21 22 23 … 72

Merck : MRK

All Merck Articles

Short Sellers Back Off Major Pharma Stocks

Apple Rolls on as Dow’s Top-Performing Stock

Boeing, Visa Prop Up the Dow Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Nike Back on Top as Dow’s Best-Performing Stock

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Nike, Johnson & Johnson Lift the Dow Monday

Apple Returns to Perch as Dow Top-Performing Stock

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Short Sellers Hike Bets in Major Pharma Stocks

Merck Underwhelms Despite Beating Earnings

Major Pharma Stocks Scare Off Short Sellers

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Donald Trump’s Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT’ Meme Stock Have Watched Billions Evaporate

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Donald Trump’s Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT’ Meme Stock Have Watched Billions Evaporate

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Merck : MRK

All Merck Articles

Short Sellers Back Off Major Pharma Stocks

Apple Rolls on as Dow’s Top-Performing Stock

Boeing, Visa Prop Up the Dow Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Nike Back on Top as Dow’s Best-Performing Stock

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Nike, Johnson & Johnson Lift the Dow Monday

Apple Returns to Perch as Dow Top-Performing Stock

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Short Sellers Hike Bets in Major Pharma Stocks

Merck Underwhelms Despite Beating Earnings

Major Pharma Stocks Scare Off Short Sellers

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Donald Trump’s Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT’ Meme Stock Have Watched Billions Evaporate

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts